New survey shows Americans want patent reform
Keytruda Qlex: Where’s the invention?
Two bipartisan bills target patent abuse
Still Overpatented, Still Overpriced
Merck’s Scheme to Product Hop Keytruda
We Need More Drug Patent Data
Five Patent Predictions for 2025
The Year in Patent Reform
The real legacy of the Hatch-Waxman Act
Why Current Legislation to Prevent Patent Thickets Are a Good Start — But Not Enough